Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05222815 · ClinicalTrials.gov registry record · NA
Glucose Monitoring Comparison in Primary Care
A NA study of Diabetes Mellitus, Type 2, sponsored by HealthPartners Institute.
- Active
- Registry status
- NA
- Development phase
- 360
- Enrollment target
- 1
- Study location
NCT05222815 is a NA study of Diabetes Mellitus, Type 2 that is active but no longer recruiting, run by HealthPartners Institute. The registered enrollment target is 360 participants, below the 4,484-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05222815, a NA study of Diabetes Mellitus, Type 2, is active but no longer recruiting, sponsored by HealthPartners Institute.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 360 participants
- Enrollment target
- 1
- Study location
Study Summary
This research trial will randomize 50 primary care clinics and 354 patients in accordance with their primary care clinic assignment to 2 different glucose monitoring strategies (SMBG vs. CGM) and compare the effectiveness through a pragmatic clinic cluster randomized design, with active glycemic management in a "usual" primary care setting, over the course of a 12 month active study period.
Conditions Studied
Interventions
- OTHER CGM
- OTHER SMBG
Study Locations (1)
Minnesota
- International Diabetes Center - Saint Louis Park
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 360 participants |
| Start Date | 2022-08-29 |
| Est. Completion | 2026-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05222815
The ClinicalTrials.gov registry entry for NCT05222815 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 360 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,484-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (92% lower). The listed sponsor is HealthPartners Institute, which has 146 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Diabetes Mellitus, Type 2 appearing as the primary indexed condition, and to 2 interventions - of which CGM is the first listed.
NCT05222815 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT05222815 about?
NCT05222815 is a clinical study titled "Glucose Monitoring Comparison in Primary Care". This research trial will randomize 50 primary care clinics and 354 patients in accordance with their primary care clinic assignment to 2 different glucose monitoring strategies (SMBG vs. CGM) and compare the effectiveness through a pragmatic clinic cluster randomized design, with active glycemic man...
What is the current status of trial NCT05222815?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 360 participants. The study started on 2022-08-29. Estimated completion is 2026-02.
What conditions does trial NCT05222815 study?
This clinical trial studies the following conditions: Diabetes Mellitus, Type 2.
What interventions are being tested in trial NCT05222815?
The interventions under investigation include: CGM (OTHER), SMBG (OTHER).
Who is sponsoring clinical trial NCT05222815?
This trial is sponsored by HealthPartners Institute, which has 146 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05222815 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus, Type 2
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Continuous Glucose Metrics in Patients With Gastroparesis in Type 1 or Type 2 Diabetes
RECRUITING · NA
-
Longitudinal Multi-Omic Profiles to Reveal Mechanisms of Obesity-Mediated Insulin Resistance
RECRUITING · NA
-
Trial to Assess Continuous Glucose Monitoring in Asian Americans With Type 2 Diabetes
RECRUITING · NA
-
Efficacy of mHealth Apps for Health in a Low-income, Type II Diabetic, Hispanic Population
RECRUITING · NA
-
Phenotyping Genetic Risk for Type 2 Diabetes
RECRUITING · NA
-
Diabetes Learning in Virtual Environments Just in Time for Community Reentry
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.